Through comprehensive RNA transcriptomic analyses, bioinformatics assessments of publicly accessible datasets and functional rescue experiments, we have demonstrated that TXNDC12 promotes tumorigenesis in HNSCC by activating the c-Myc signaling pathway, primarily through enhancing its stability. This evidence concerns the gene MYC and head and neck squamous cell carcinoma.